EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effects of arketamine on depression-like behaviors and demyelination in mice exposed to chronic restrain stress: A role of transforming growth factor-β1

Dan Xu, Guilin Liu, Mingming Zhao, Xiayun Wan, Youge Qu, Rumi Murayama, Kenji Hashimoto

Journal of Affective Disorders · 2024

DOI: 10.1016/j.jad.2024.08.222 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Affective Disorders, 2024. Verfasst von Dan Xu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Chiba University Center for Forensic Mental Health, Chiba 260-8670, Japan; Department of Critical Care Medicine, Union Hospital, Tongji Medical Colle…. Hauptthemen laut MEDLINE: Ketamine, Transforming Growth Factor beta1, Depression, Stress, Psychological. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Japan Science and Technology Agency.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Chronic restrain stress (CRS) induces depression-like behaviors and demyelination in the brain; however, the relationship between these depression-like behaviors and demyelination remains unclear. Arketamine, the (R)-enantiomer of ketamine, has shown rapid antidepressant-like effects in CRS-exposed mice. METHODS: We examined whether arketamine can improve both depression-like behaviors and demyelination in the brains of CRS-exposed mice. Additionally, we investigated the role of transforming growth factor β1 (TGF-β1) in the beneficial effects of arketamine. RESULTS: A single dose of arketamine (10 mg/kg) improved both depression-like behavior and demyelination in the corpus callosum of CRS-exposed mice. Correlations were found between depression-like behaviors and demyelination in this region. Furthermore, pretreatment with RepSox, an inhibitor of TGF-β1 receptor, significantly blocked the beneficial effects of arketamine on depression-like behaviors and demyelination in CRS-exposed mice. Finally, a single intranasal administration of TGF-β1 ameliorated both depression-like behaviors and demyelination in CRS-exposed mice. LIMITATIONS: The precise mechanisms by which TGF-β1 contributes to the effects of arketamine remain unclear. CONCLUSIONS: These data suggest that CRS-induced demyelination in the corpus callosum may contribute to depression-like behaviors, and that arketamine can mitigate these changes through a TGF-β1-dependent mechanism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

KetamineTransforming Growth Factor beta1DepressionStress, PsychologicalDemyelinating DiseasesCorpus CallosumDisease Models, AnimalAnimalsMiceMaleAntidepressive AgentsBehavior, AnimalRestraint, PhysicalMice, Inbred C57BL

Stichwörter der Autor:innen

AntidepressantArketamineChronic stressDemyelinationDepressionTGF-β1

Substanzen

KetamineTransforming Growth Factor beta1Antidepressive Agents

Autor:innen und Institutionen

  • Chiba University Center for Forensic Mental Health, Chiba 260-8670, Japan; Department of Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, PR Ch…
  • Chiba University Center for Forensic Mental Health, Chiba 260-8670, Japan; Department of Anesthesiology, The Affiliated Hospital of Qingdao University, Qingdao 266100, PR China.
  • Chiba University Center for Forensic Mental Health, Chiba 260-8670, Japan; Department of Anesthesiology, Pain and Perioperative Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, PR China.
  • Chiba University Center for Forensic Mental Health, Chiba 260-8670, Japan.
  • Chiba University Center for Forensic Mental Health, Chiba 260-8670, Japan; Laboratory of Chemical Pharmacology, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba 260-8675, Japan.
  • Chiba University Center for Forensic Mental Health, Chiba 260-8670, Japan. Electronic address: hashimoto@faculty.chiba-u.jp.

Förderung

  • Japan Society for the Promotion of Science
  • Japan Science and Technology Agency

Zitieren

APA

Xu, D., Liu, G., Zhao, M., Wan, X., Qu, Y., Murayama, R., & Hashimoto, K. (2024). Effects of arketamine on depression-like behaviors and demyelination in mice exposed to chronic restrain stress: A role of transforming growth factor-β1. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2024.08.222

Vancouver

Xu D, Liu G, Zhao M, Wan X, Qu Y, Murayama R, et al. Effects of arketamine on depression-like behaviors and demyelination in mice exposed to chronic restrain stress: A role of transforming growth factor-β1. Journal of Affective Disorders. 2024. doi:10.1016/j.jad.2024.08.222

BibTeX
@article{Xu2024,
  author = {Xu, Dan and Liu, Guilin and Zhao, Mingming and Wan, Xiayun and Qu, Youge and Murayama, Rumi and Hashimoto, Kenji},
  title = {Effects of arketamine on depression-like behaviors and demyelination in mice exposed to chronic restrain stress: A role of transforming growth factor-β1},
  journal = {Journal of Affective Disorders},
  year = {2024},
  doi = {10.1016/j.jad.2024.08.222}
}
Kostenlos starten →